Cancer Care
Sarah Green, PA-C specializes in overall wellness, including primary care, preventative medicine, and cutting-edge cancer care through scientific discovery, innovation, and application. Sarah uses RGCC, a liquid biopsy founded by genetics pioneer Dr. Ioannis Papasotiriou, to establish patient-centric solutions that go beyond traditional treatment approaches. At Elevate Your Wellness Center, we strongly believe that personalized medicine is the future of cancer treatment. To improve the chances of successful treatment and survival, RGCC services help our patients make informed decisions and help to formulate effective treatment plans.
A PROACTIVE STEP TOWARDS EARLY DETECTION
Onco-D-clare is a cancer screening test designed to identify cancer even before the symptom's onset. With the ease of a simple blood draw, we can now detect cancer long before and symptoms emerge. Onco-D-clare opens an early door to personalized health insights. The Onco-D-clare test goes beyond traditional screening, aiming to detect cancer at it's earliest stages. It is designed as an early screening tool for individuals who do not have a cancer diagnosis but may want to stay informed about their risk. This is especially useful for those who have a family history of cancer or other risk factors.
A POWERFUL ALLY IN THE FIGHT AGAINST CANCER
Onconomics Plus compiles extensive data on the effectiveness of conventional treatments, distinguishing between the effective and ineffective options. It also provides insights into natural compounds that can effectively combat cancer. The artful selection of conventional and natural agents, when combined, created a comprehensive treatment plan addressing the cancer, targeting cancer stem cells, and mitigating the spread of the disease.
Why choose the Onconomics Plus test? Through a combination of three assessments, the test evaluates the chemosensitivity of anti-cancer drugs, natural substances, and gene expressions profiling. This test equips Sarah Green, PA and the medical scientists she works with, along with the patient, to establish a protocol and identify the best way forward to offer insightful treatment options. This test arms the team with the knowledge to make informed decisions, maximizing the likelihood of success, and minimizing guesswork. It helps to determine which supplements or chemotherapy treatments are likely to succeed and which are likely to fail.
PRECISION GENE SILENCING THERAPY
Q-REstrain is an innovative RNA interference therapy using your own cellular material to silence disease-specific gene sequences. Q-REstrain is a breakthrough autologous therapy that harnesses your body's own genetic material to fight disease. We analyze your blood sample to identify and target disease-specific gene-sequences using advanced RNA interference (RNAi) technology.